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Abstract
Background: The role of inflammation in the pathogenesis of non-alcoholic steatohepatitis (NASH), a common cause of liver
disease, is still poorly understood. This study aimed at assessing the involvement of a major inflammatory cytokine, IL-6, in
NASH.
Materials and Methods: Steatohepatitis was induced by feeding wild-type or IL-6
2/2 mice for 5 weeks with a methionine
and choline-deficient (MCD) diet.
Results: Whereas MCD diet-induced weight loss and decreases in serum glucose, cholesterol and triglyceride levels were
similar in both genotypes, serum alanine aminotransferase was less elevated in IL-6
2/2 mice than in wild-type animals.
Despite having a comparable liver steatosis score, IL-6-deficient mice exhibited less lobular inflammation than their wild-
type littermates. Liver gene expression of TGF-b and MCP-1 was also strongly attenuated in mutant mice; a more modest
reduction was observed for PPAR-c and F4/80 transcripts as well as proteins. Chromatographic analysis of liver lipids
demonstrated that MCD diet induced in normal and mutant mice a similar decrease in the ratio of phosphatidylcholine to
phosphatidylethanolamine. However, the diet-induced increase in the levels of sphingomyelin and ceramide was less
important in IL-6
2/2 mice.
Conclusion: Altogether, these results indicate that IL-6 deficiency does not block the development of NASH; yet, IL-6 plays a
critical role in the accompanying liver inflammation.
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Introduction
The term non-alcoholic steatohepatitis (NASH) was first used in
1980 by Ludwig et al. [1] to describe a histological pattern that
mimicked alcoholic hepatitis but occurred in patients without
history of alcohol abuse. The features of NASH on liver biopsy
include steatosis, inflammation, liver cell injury and varying
degrees of fibrosis. NASH belongs to the spectrum of non-
alcoholic fatty liver disease (NAFLD) and is becoming a major
public health problem because it is associated with obesity, insulin
resistance and the metabolic syndrome. Therefore, NASH is
believed to affect approximately 3% of adults in Western countries
and represents, together with alcohol and hepatitis C virus
infection, one of the main etiologies of cirrhosis [2].
A ‘two-hit process’ has been proposed to underlie the
pathophysiology of NASH [3]. According to this concept, in the
first hit, there is an increase of circulating free fatty acids resulting in
liver steatosis. This step is enhanced by insulin resistance, which
appearstoplay a prominent role.Secondaryinsults(‘the second hit’)
include oxidative stress, whereby production of radical oxygen
species and lipid peroxidation occur, recruitment of inflammatory
cells and dysregulated cytokine/adipokine production. This induces
hepatocyte cell death, by apoptosis or necrosis, and subsequent liver
inflammation and fibrosis. A current, more integrated hypothesis
suggests the involvement of multiple and interconnected events [4].
Whereasthemolecularmechanismsleadingfromliversteatosisto
NASH (or from NASH to cirrhosis) still remain unclear, hepatic
inflammatory cell recruitment appears as a key step, and the
contribution of inflammatory cytokines such as tumor necrosis
factor (TNF)-a or interleukin-6 (IL-6) seems obvious. Nevertheless,
despite recent work on TNFa inthe pathogenesis of NASH, the role
of this pro-inflammatory cytokine is still a matter of debate. TNFa is
known to play a central role in insulin resistance [5] and is critically
involved in alcoholic steatohepatitis [6]. Moreover, liver and
adipose tissue TNFa and TNF receptor 1 (TNFR1) transcripts [7]
as well as serum TNFa levels [8] are increased in patients with
PLoS ONE | www.plosone.org 1 November 2009 | Volume 4 | Issue 11 | e7929NASH. While these observations point to some contribution of
TNFa to the pathogenesis of NASH, recent studies on animal
models have led conflicting conclusions. For instance, deficiency of
TNF receptors did not prevent elevation of serum ALT in ob/ob
mice [9] or after intragastric overfeeding of a high-fat diet [10].
However, TNFR1-deficient mice fed a high sucrose diet did not
manifest steatosis [11], and liver steatosis and fibrosis were
attenuated in doubly TNFR1/TNFR2-deficient mice fed a
methionine and choline-deficient (MCD) diet [12]. With regard to
IL-6, a pleiotropic cytokine which regulates inflammatory responses
and represents another putative mediator of steatohepatitis, its
precise role in NASH is almost unknown (see Discussion).
The present study was therefore undertaken to clarify the place
of IL-6 in the development of NASH. For this purpose, IL-6-
deficient (IL6
-/-) mice were analysed. We used MCD diet to
induce experimental NASH because of the reproducibility of this
well-established model that allows the assessment of the inflam-
matory pathway despite the absence of insulin-resistance [13–15].
This is a frequently employed nutritional model, where steatosis
appears and serum ALT levels increase after 3 weeks, followed by
focal inflammation and fibrosis after 5 and 8 weeks, respectively.
In this model, lipid storage is believed to be the consequences of
increased fatty acid uptake and decreased VLDL secretion
[16,17]. The histological changes are morphologically similar to
those observed in human NASH. Our biochemical, histological
and molecular analyses indicate that in mice IL-6 contributes to
the MCD diet-induced liver inflammation.
Materials and Methods
Ethics Statement
All animal experimentation was conducted in accordance with
accepted standards of humane animal care (recommendations of
the European Accreditation of Laboratory Animal Care). Mouse
experiments were approved and performed according to the
guidelines of the Toulouse University Midi-Pyre ´ne ´es Regional
Animal Safety Committee.
Animal Experiments
Ten-week-old C57BL/6 male mice, either WT or deficient for
IL-6, were fed a MCD diet (MP Biomedicals, France) or a normal
diet (2016 Teklad Global 16% Protein Rodent Diet) for 5 weeks.
IL-6
2/2 mice [18] were kindly provided by Dr. M. Thomsen
(Inserm U858, Toulouse, France). Animals had unrestricted access
to food and water, were housed in temperature-controlled rooms
(in the specific pathogen-free animal facility of IFR31, Toulouse)
and kept on a 12-hour light/dark cycle. Mice were anaesthetised
with fluothane inhalation and about 300 ml of blood was collected
by retro-orbital puncture. Mice were sacrificed by cervical
dislocation. Livers were rapidly excised and rinsed in phosphate
buffered saline (PBS). Two slides of the largest lobe were fixed in
10% formaldehyde for histological analyses and the remaining
liver was immediately frozen at 280uC for other analyses.
Morphologic Studies
Liver was embedded into paraffin and sections were cut and
stained with hematoxylin eosin (HE), Oil Red O or Masson
trichrome. Evaluation was performed by a single blinded
pathologist (M.D). The criteria used were steatosis, lobular and
portal inflammation, portal fibrosis, cellular ballooning, lipogra-
nuloma, and apoptosis, according to Brunt et al. [19]. Based on
these criteria, the NAFL (non-alcoholic fatty liver) Activity Score
was calculated, which allows to distinguish NASH (NAFL
score$5), borderline (3 to 4) or no NASH (,3) [20].
Immunohistochemistry of paraffin-embedded liver sections was
carried out using an anti-F4/80 antibody (MCA497, Serotec) to
characterize macrophagic cells.
Blood Tests
Serum was collected after a 20 min centrifugation at 1000 x g.
Glucose levels were measured using a Glucotrend 2H analyser
(Roche Diagnostics, France), and triglyceride, cholesterol and
ALT levels were determined using a Cobas MIRA analyser.
Liver Lipid Analyses
A 100 mg portion of the liver was transferred into 1 ml of buffer
(10 mM Hepes-KOH pH 7.4, 42 mM KCl, 5 mM MgCl2,1m M
dithiothreitol, 0.5% CHAPS, 1 mM PMSF, and 2 mg/ml leupep-
tin). Liver was homogenised at 4uC using a Turrax homogeniser
(2610 sec), followed by sonication (265 sec) with a tip Soniprep
sonicator. An aliquot of liver homogenate was centrifuged for
10 min at 500 x g at 4uC. The supernatant was used for protein
analysis by the Bradford method [21] and stored for further
analyses. Lipids were extracted according to Folch et al [22].
Briefly, 300 ml of distilled water and 2.5 ml of chloroform/
methanol (2/1, by vol.) were added to 200 ml of liver homogenate;
after vigorous mixing and centrifugation, the lower organic phase
was isolated and evaporated under a nitrogen stream.
Total liver phospholipids were determined by measuring the
content of inorganic phosphorus [23]. For quantification of
sphingomyelin, the lipid extract was first submitted to mild
alkaline methanolysis (to degrade acylglycerophospholipids) and
resistant lipids (i.e., sphingomyelin) were reisolated for determina-
tion of the phosphorus content as described above. Individual
glycerophospholipid species were separated by high performance
liquid chromatography (Lipidomic core, IFR30, Toulouse).
Ceramide levels were determined by using E. coli diacylglycerol
kinase and [c
32P]-ATP as previously described [24].
Liver Lipid Peroxide Determination
Total lipoperoxides were measured as thiobarbituric acid-
reactive substances (TBARS) in 50 and 100 ml of liver homogenate
[25]. Briefly, after addition of water (to a final volume of 1 ml),
0.5N HCl (100 ml) and thiobarbituric acid (1 ml), and heating at
95uC in the darkness for 20 min, butanol (2 ml) was added. After
centrifugation for 10 min at 500 g at 4uC, the fluorescence
intensity of the supernatant was recorded using a Jobin-Yvon
spectrofluorimeter (at 515 nm and 548 nm for the excitation and
emission wavelength, respectively). TBARS were quantified using
malondialdehyde (MDA) as a standard.
Assessment of Apoptosis
Several techniques to assess apoptosis were employed. DEVDase
activity was measured by fluorometry on a 100 ml aliquot of the liver
homogenate supernatant [26]. Caspase-3 processing was also
analysed by Western blotting. Total liver proteins (30 mg) were
separated on 15% PAGE. We used a rabbit primary anti-caspase-3
antibody (Cell Signaling); complexes were revealed with a Super-
SignalH West Dura Substrate kit (Pierce Biotechnology, USA).
Finally, DNA fragmentation was studied. After an overnight digestion
of 100 mg of liver with proteinase K at 55uC, DNA was extracted
using a chloroform/phenol method. Twenty-five mgo fD N Aw e r e
migrated on 2% agarose gel containing ethidium bromide.
Determination of mRNA Levels
RNA extraction was performed using RNA STAT-60H (Ams
Biotechnology, UK). cDNA was obtained using 1 mg of total RNA
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Transcriptase (Invitrogen). Real-time quantitative PCR was
carried out using primers for F4/80, GAPDH, HPRT, IL-6,
MCP-1, PPAR-c1/2, TGF-b, and TNFa, and with Power SYBRH
Green PCR Master Mix (Applied Biosystems, UK). We used an
ABI 7900 analyser (Applied Biosystems). Sequences for primers
are indicated in Table 1.
Western Blotting Analyses
Equal amounts of proteins (50 mg) were extracted from livers,
electrophoresed on a 10% SDS-polyacrylamide gel, transferred to
a nitrocellulose membrane (Perkin-Elmer) and blotted with anti-
Foxp3 (14-7979, eBioscience) and PPAR-c (sc-7273, Santa-Cruz).
Proteins were detected using an ECL detection system (Thermo
Scientific). Secondary antibodies were from Cell Signaling
Technology.
Data Analysis
Numerical data are expressed as means6SEM. Statistical
analysis was performed using unpaired Student t test and Chi
2
test, for continuous or categorical variables respectively. Values of
p,0.05 were considered significant.
Results
Effects of MCD Diet on Anthropometric Parameters,
Serum Glucose and Lipid Levels
WT mice were slightly heavier than IL-6
2/2 mice but both
control and mutant mice lost about one third of their initial body
weight after 5 weeks of MCD diet (Fig. 1A). There was no liver
enlargement and the liver weight even decreased by about 50% on
MCD diet (Fig. 1B). Without fasting, MCD diet induced a marked
decrease in serum glucose, triglyceride and cholesterol levels as
compared to a normal diet (Fig. 1C, D and E). This decrease was
comparable in WT and IL-6
2/2 mice. Cholesterol levels,
however, remained slightly higher in mutant mice.
Hepatic Injury on MCD Diet
Feeding mice with MCD diet resulted in a 5.5-fold increased
level of ALT. This biochemical liver injury induced by MCD diet
was similar in WT and IL-6
2/2 mice (Fig. 1F). Increased ALT
levels were already present at 3 weeks (not shown).
Histological analysis revealed that the steatosis induced by
MCD diet was similar for all animals (Fig. 2A). Steatosis was
assessed using HE staining but also with Oil Red O (not shown).
Cellular ballooning appeared quite mild and comparable for all
types of mice (not shown). As illustrated in representative sections,
the liver of WT mice fed the normal diet was normal (Fig. 2D)
whereas on the MCD diet it contained large fat droplets and
clusters of inflammatory cells (Fig. 2E). But the number of
inflammatory cells and clusters were reduced in IL-6
2/2 mice
(Fig. 2F). Indeed, the lobular inflammation detected in mice fed
the MCD diet was mild to moderate for IL-6
2/2 mice, whereas it
was moderate to severe for WT animals (Fig. 2B). Finally, after
MCD feeding, the NAFL Activity Score [20] was lower in IL-6
2/2
mice (p=0.04) than in WT animals, with respectively 50% and
90% of confirmed NASH (Fig. 2C). After 5 weeks on MCD diet,
fibrosis could not be detected on Masson trichrome-stained
sections for both genotypes (not shown). Of note, under a normal
diet, the steatosis and lobular inflammation scores were similar in
WT and IL6-deficient mice.
Absence of Apoptosis Associated with Steatohepatitis
Development of steatohepatitis, including NASH, has been
shown to be associated with liver apoptosis [12,27–32]. In the liver
from mice fed the MCD diet for 5 weeks, we did not find any sign
of apoptosis whatever the genotype and the NAFL Activity Score.
Indeed, there were no increase of DEVDase (effector caspase)
activity, no proteolytic cleavage of caspase-3, no DNA fragmen-
tation, and no apoptotic bodies on histological examination. We
therefore concluded that, by that time of MCD diet feeding, liver
apoptosis is not a prominent phenomenon contributing to NASH.
Alterations in Liver Lipid Metabolism
Besides the storage of triacylglycerols, steatohepatitis is known
to be associated with alterations in liver phospholipid metabolism
[33,34]. Insulin resistance is also associated with increased
intracellular content of fatty acids and their metabolites, including
ceramide [35,36]. In addition, cytokines such as TNFa and IL-6,
which might participate in the pathogenesis of NASH, elicit
changes in sphingolipid metabolism and stimulate the production
of bioactive lipids, such as ceramide, which behave as second
messengers [36–38]. We thus analysed the glycerophospholipid
and sphingolipid composition of the livers from mice fed a MCD
diet. As shown in Fig. 3C, feeding for 5 weeks the MCD diet
resulted in a decrease of the phosphatidylcholine to phosphatidyl-
ethanolamine (PC/PE) ratio of approximately 50%. This decrease
was comparable for control and IL-6-deficient mice, although the
PC levels slightly increased in WT but decreased in mutant mice,
in which the basal levels were higher (Fig. 3A). Under conditions of
feeding a normal diet, the liver content of total phospholipids (not
shown) as well as that of sphingomyelin, the major sphingopho-
spholipid, was higher in IL-6
2/2 mice than in WT animals
(Fig. 3D). The same applied for the ceramide content (Fig. 3E).
After 5 weeks of MCD diet, livers exhibited an increase both in the
sphingomyelin and ceramide concentrations for all mice. Howev-
er, whereas the content of these two lipids increased by more than
2.6-fold in WT mice (p,0.001 for sphingomyelin and ceramide), it
did not increase by more than 1.5-fold in IL-6
2/2 animals
(p,0.001 for sphingomyelin and p=0.01 for ceramide). A lesser
elevation of ceramide in mutant mice was also observed when
normalizing to total phospholipids (Fig. 3F).
Lipid Peroxidation
Because NASH is often associated with lipid peroxidation
[25,31,32,39,40] we next sought to assess the importance of this
phenomenon in IL-6
2/2 mice. Liver peroxides were measured
through the quantification of TBARS. Figure 4 shows that, on a
normal diet the liver TBARS content was higher (p=0.03) for IL-
6
2/2 mice than for WT mice. As expected, these levels increased
on MCD diet, but this increase was only 1.7-fold in mutant mice
(p,0.001) as compared to 3.3-fold in WT mice (p,0.001).
Table 1. Sequences of primers used for quantitative RT-PCR.
Gene Sense Antisense
PPAR-c1/2 CCGAAGAACCATCCGATTGA TTTGTGGATCCGGCAGTTAAG
TGF-b GAGCCCGAAGCGGACTACTA CACTGCTTCCCGAATGTCTGA
MCP-1 GCAGTTAACGCCCCACTCA CCAGCCTACTCATTGGGATCA
F4/80 TGACAACCAGACGGCTTGTG GCAGGCGAGGAAAAGATAGTGT
HPRT TGGCCATCTGCCTAGTAAAGC GGACGCAGCAACTGACATTTC
GAPDH TGCACCACCAACTGCTTAGC GGCATGGACTGTGGTCATGAG
All sequences are oriented, from left to right, 59 to 39.
doi:10.1371/journal.pone.0007929.t001
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Fibrosing Response in IL-6
2/2 Mice
In accordance with the fact that steatosis is associated with
hepatic expression of PPAR-c, MCD diet induced an increased
PPAR-c1/2 gene expression in all mice (Fig. 5A). However, the
level of PPAR-c1, 2 transcripts was higher in WT mice than in IL-
6
2/2 mice, although a similar difference existed on a normal diet.
As illustrated in Fig. 5B, mRNA levels of the fibrogenesis mediator
TGF-b significantly increased on MCD diet only in WT mice.
The expression level of this gene was lower on MCD diet in IL-
6
2/2 mice than in WT mice. The expression of the monocyte
chemoattractant protein MCP-1 increased 11-fold on MCD diet
in WT mice (Fig. 5C). Of interest, despite a modest (25–30%)
increase on MCD diet, MCP-1 mRNA levels remained extremely
low in IL-6
2/2 mice. Finally, in accordance with the decreased
inflammation observed histologically, the mRNA levels of the
macrophage marker F4/80 that were similar on a normal diet
increased by 233 and 159% on MCD diet in WT and IL-6
2/2
mice, respectively (Fig. 5D). Although TNF was generally
expressed at a lower level than the other genes examined, on
MCD diet its levels were increased by 12-fold in WT mice but only
6-fold in IL-6-deficient mice (not shown). While undetectable in
mutant mice, the level of IL-6 gene expression in WT animals was
not increased after 5 weeks of MCD diet feeding (not shown). This
finding would be in agreement with a recent study in which
hepatic IL-6 levels were determined after 6 weeks feeding a liquid
MCD diet [41] and is likely related to the fact that it was measured
at a too late point.
To test whether some of the changes observed above for mRNA
translated into changes of the corresponding proteins, we
performed Western blotting experiments on liver lysates. As
illustrated in Fig. 6, the levels of PPAR-c increased in both
genotypes after MCD diet feeding. However, they remained
significantly lower in IL-6
2/2 mice. We also tested the expression
of Foxp3, a master transcription factor for TGF-b-induced
differentiation of T regulatory cells. Figure 6 shows that induction
of Foxp3 during the MCD diet was abolished in IL-6-deficient
animals.
Figure 1. MCD diet results in loss of body and liver weights, hypoglycemia, hypotriglyceridemia, hypocholesterolemia, and
increased serum alanine aminotransferase (ALT) activity. After 5 weeks of a MCD diet, body (A) and liver (B) weights, serum levels of glucose
(C), triacylglycerols (D), cholesterol (E), and ALT (F) of WT and IL-6
2/2 mice were determined. Data are means6SEM; the number of animals is
indicated into each column. Asterisks denote significant differences (* p,0.05, ** p,0.01, *** p,0.001) between mice of different genotypes on the
MCD diet (when indicated above the line) or between different diets for the same genotype (when indicated in A and above the columns).
$$$ indicates a difference (p,0.001) between IL-6
2/2 and WT mice on a normal diet.
doi:10.1371/journal.pone.0007929.g001
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Kupffer cells was studied histologically by examining F4/80-
positive cells in the liver samples. In the animals fed a normal diet,
Kupffer cells remained isolated, being only present in sinusoids
(Fig. 7A and C). MCD diet feeding caused recruitment of Kupffer
cells into clusters (Fig. 7B and D). While macrophage clusters
seemed to be less abundant in IL-6
2/2 mice, the difference did not
reach statistical significance (p=0.09).
Discussion
The role of inflammatory cytokines in the development of
NASH has not yet been fully elucidated. Despite recent studies on
different rodent models, the contribution of TNFa to the
pathogenesis of NASH remains unclear. Indeed, studies on mice
deficient for TNFa or its receptors using different conditions to
induce liver steatosis have not led to unequivocal conclusions. The
Figure 2. Effect of IL-6 deficiency on MCD diet-induced steatohepatitis. After 5 weeks of a MCD diet, mice were sacrificed and the liver was
examined for scoring steatosis (A), ballooning (not shown) and lobular inflammation (B). The NAFL (non-alcoholic fatty liver) activity score was
calculated (C). Representative sections of hematoxylin/eosin-stained liver of WT mice on normal (D) or MCD diet (E), or of IL-6
2/2 mice on MCD diet
(F), are shown. Liver sections of WT mice (E) revealed large fat droplets and the presence of inflammatory cells. In IL-6
2/2 mice, steatosis was similarly
present, but the number of inflammatory cells was decreased. The number of animals per group was 12 and 11 for WT mice, and 10 and 10 for IL-6
2/2
mice fed a normal or MCD diet, respectively. * p,0.05, *** p,0.001.
doi:10.1371/journal.pone.0007929.g002
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but influences its development [9,10,12]. As to IL-6, its
contribution to NASH has remained almost totally elusive. Using
a well-established nutritional model of NASH induction [13–15],
the present study demonstrates that IL-6 certainly participates to
the NASH-associated inflammation but is dispensable for the
appearance of the disease. Whereas liver inflammation was
markedly reduced in mice deficient for IL-6, as revealed both
histologically and by analysing gene expression, liver injury and
changes in lipid composition and peroxidation still occurred in
mutant mice.
This is the first study to shed light on the role of IL-6 in a dietary
model of NASH. In this model, IL-6 does not constitute the critical
driving force for NASH but appears to modulate the inflammatory
response rather than the initiation of the steatosis itself. In mice,
IL-6 deficiency has been reported to induce a mature-onset obesity
that appears after 6 months of life [42]. In the latter study, an
increase in blood triglyceride levels was found that occurred only
in females. The effect of IL-6 was supposed to be central. Of note,
such an effect was not observed in the present study since we used
younger males that lost weight on the MCD diet and that were
slightly lighter than controls. Moreover, triglyceride levels equally
decreased in both genotypes fed the MCD diet. These data
strongly suggest that the alterations in lipid metabolism previously
described in aged IL6-deficient females do not interfere with the
present findings and interpretation.
IL-6 expression is known to be stimulated upon TNFa-
mediated activation of NF-kB, a transcription factor believed to
play a central role in NASH [40]. Not only has IL-6 been linked to
insulin resistance [43] but also IL-6 level is increased in serum of
patients with NASH [44], NAFLD [45] or alcoholic hepatitis [46].
The role of IL-6 in hepatic dysfunction in general, and insulin
sensitivity and NASH in particular, remains, however, unclear
[47–49]. Indeed, administration of IL-6 to IL-6
2/2 mice was
shown to prevent the massive liver necrosis after partial
hepatectomy, suggesting an important role of this cytokine in
hepatocyte regeneration [50]. Moreover, IL-6-deficient mice were
highly susceptible to sepsis-induced steatosis and hepatocellular
injury [51]. More recently, treatment of mice with IL-6
ameliorated steatosis in different models of fatty liver, including
ob/ob mice and ethanol-fed mice [52–54]. Whether IL-6 plays a
protective or injurious role on liver may depend on the duration of
exposure to stress [30]. Furthermore, the cytokine action may be
influenced by the local milieu [55] and, as examplified by the case
of IL-6 on insulin sensitivity, the duality of IL-6 functions is likely
tissue-specific and physiological context-dependent [56].
Here we show that genetic deletion of IL-6 markedly attenuates
hepatic inflammation in MCD diet-induced NASH. This effect
was observed both histologically and by quantitation of hepatic
Figure 3. Effects of IL-6 deficiency on liver lipid content. Lipids were extracted from the livers of mice fed a normal or the MCD diet for 5
weeks. Phosphatidylcholine (PC, panel A) and phosphatidylethanolamine (PE, panel B) levels were measured by HPLC, and the PC/PE ratio (C) was
calculated. The levels of sphingomyelin (D) were determined by inorganic phosphorus analysis preceded of alkaline methanolysis, and those of
ceramide (E) were measured by the diacylglycerol kinase assay. In panel F, ceramide is expressed as the ratio to total phospholipids. Data are
expressed as in the legend to Fig. 1. Further symbols ($ p,0.05, $$ p,0.01, $$$ p,0.001) indicate differences between IL-6
2/2 and WT mice on a
normal diet.
doi:10.1371/journal.pone.0007929.g003
Figure 4. Effect of IL-6 deficiency on MCD diet-induced
peroxidation of liver lipids. Total lipoperoxides were measured as
TBARS. Each determination was performed in duplicate. Data are
means6SEM; the number of animals is indicated into each column. The
asterisks denote a significant difference between diets for the same
genotype (***, p,0.001), and $ a difference (p,0.05) between IL-6
2/2
and WT mice on a normal diet.
doi:10.1371/journal.pone.0007929.g004
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MCP-1 (C), and F4/80 (D) were measured by quantitative RT-PCR and normalized to the level of HPRT mRNA. Results are expressed as the percentage
of the levels found in WT mice fed a normal diet. Each determination was performed in duplicate. Data are means6SEM; the number of animals is
indicated into each column. Asterisks denote significant differences (* p,0.05, ** p,0.01, *** p,0.001) between mice of different genotypes on the
same diet (when indicated above the line) or between different diets for the same genotype (when indicated above the columns). Further symbols
($ p,0.05, $$ p,0.01) indicate differences between IL-6
2/2 and WT mice on a normal diet.
doi:10.1371/journal.pone.0007929.g005
Figure 6. Effects of IL-6 deficiency on MCD diet-induced changes in liver expression of PPAR-c and Foxp3. Equal amounts of protein
(50 mg) were analyzed by Western blotting (representative images on the left panels). Densitometric analysis of the blots is presented on the right
panels. Data are means6SEM; the number of animals is indicated into each column. Asterisks denote significant differences (* p,0.05, ** p,0.01,
*** p,0.001) between mice of different genotypes on the same diet (when indicated above the line) or between different diets for the same
genotype (when indicated above the columns).
doi:10.1371/journal.pone.0007929.g006
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promote liver fibrosis. Histologically, upon hematoxylin/eosin
staining, whereas the nature of inflammatory cells (i.e., neutrophils
and lymphocytes; data not shown) was similar in control and IL-6-
deficient mice, there was less lobular inflammation in mutant
mice. This was concordant with F4/80 staining. The most
prominent difference between WT and IL-6-deficient animals
was a virtually complete abrogation in mutant mice of the diet-
induced increase in the expression of MCP-1 and TGF-b, i.e.,
factors that recruit inflammatory cells and activate hepatic stellate
cells, respectively. Along with the reduction in TGF-b expression,
the induction of Foxp3 was suppressed in IL-6-deficient mice,
suggesting that in this disease model IL-6 modulates differentiation
of Foxp3-positive T regulatory cells through TGF-b production.
Whether Th17 cells, whose differentiation is also modulated by IL-
6 [57], are involved in NASH would require further investigation.
The possibility that SOCS (suppressor of cytokine signaling)
proteins, known as critical targets of IL-6 in liver, serve as
downstream mediators in this dietary model of NASH needs to be
investigated. Also, the cellular origin of IL-6 would deserve careful
investigation. To date, the cells that produce or react to IL-6
within the liver are not really known. Both Kupffer cells and
hepatocytes are candidates. The IL-6 receptor is present on
hepatocytes and some leukocytes but other cells can interact with a
complex of IL-6 and its soluble receptor [58].
The present study further shows alterations in lipid homeostasis
in NASH and provides novel insights into the role of these
modifications to the initiation of associated inflammation. Regard-
ing the changes in the liver content of PC and PE, which we
observed and are expected because of the depletion of both choline
and methionine [16], it was recently suggested that the relative
depletion of PC or, perhaps more importantly, the decreased PC/
PE ratio results in a loss of membrane integrity and influences liver
damage [33]. Whether such a decrease in PC/PE ratio is the cause
or consequence of progression to steatohepatitis was not established.
Our study now indicates that the phospholipid changes precede,
rather than follow, the inflammatory process since similar lipid
alterations were seen in mice where inflammation is partly halted.
Whereas changes in the liver glycerophospholipid content have
already been documented, this is the first study to report changes
Figure 7. Effect of IL-6 deficiency on Kupffer cell activation during MCD diet-induced steatohepatitis. Representative pictures of
immunohistochemical detection of F4/80-positive cells in the liver of WT and IL-6
2/2 mice on normal (A and C) or MCD diet (B and D), respectively,
are shown. Arrowheads indicate isolated Kupffer cells whereas arrows show macrophage clusters. The abundance of isolated cells and clusters was
estimated in 12 and 11 livers for WT mice, and 10 and 10 for IL-6
2/2 mice fed a normal or MCD diet, respectively (** p,0.01, *** p,0.001 when
comparing different diets for the same genotype).
doi:10.1371/journal.pone.0007929.g007
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induced NASH. Irrespective of the cytokine defect, we found an
elevation of hepatic levels of these two lipids. This is in accordance
with a very recent lipidomic study that described a trend of
increased hepatic content of sphingomyelin in patients with NASH
[34]. The mechanisms and biological implications of these changes
to the pathogenesis of NASH are still far from clear. It is possible
that hepatocytes increase the synthesis of sphingomyelin, a
membrane choline-containing phospholipid analogous to PC, to
compensate for the loss of glycerophospholipids. Such synthesis of
sphingomyelin probably occurs through increased de novo synthesis
of ceramide, possibly because of enhanced incorporation of free
fatty acids. Given the reported role of ceramide in hepatocellular
death and, in general, as a bioactive lipid with pro-apoptotic
properties [36,59], it is tempting to speculate that the increased
content of ceramide participates to NASH liver injury. Generation
of this ceramide seems to be partially dependent on the production
of inflammatory cytokines since the liver ceramide content of IL-
6
2/2 mice did not increase as much as in WT animals. Still for
unclear reasons, the basal levels of both sphingomyelin and
ceramide were higher in IL-6
2/2 mice as compared to control
animals; however, when normalized to total phospholipids, the
basal ceramide levels were identical in both genotypes. Whether
ceramide plays an instrumental role in the development of
steatohepatitis remains to be investigated.
In conclusion, the present study demonstrates that IL-6 does
contribute to the inflammatory process associated with the
development of NASH. Because the dietary model of NASH we
used does not induce obesity or insulin resistance, i.e. important
features of the human condition, future studies using different
models of NASH should shed further light on the role of IL-6 in
the development of steatohepatitis. Of particular interest is the
recent observation that IL-6 expression is increased in the liver of
patients with NASH, is associated with elevation of circulating IL-
6 levels, and correlates with disease severity [60]. Further attention
should thus be paid to IL-6 as a potential pathogenic mechanism
in NASH.
Acknowledgments
The authors thank M.F. Frisach, C. Nevoit, N. Therville, Dr. Y. Barreira
(Animal facility, IFR31, Toulouse), J. Bertrand-Michel (Lipidomic core,
IFR30, Toulouse), C. Rolland (IFR30), L. Montbrun (IFR31), and F.
Capilla (Experimental Histopathology core, IFR30) for technical assis-
tance. We also thank Dr. M. Thomsen for providing IL-6-deficient mice
and Dr. J.P. Jaffre ´zou for critical reading.
Author Contributions
Conceived and designed the experiments: EM BS TL. Performed the
experiments: EM MD VG SC. Analyzed the data: EM MD BS TL.
Contributed reagents/materials/analysis tools: EM TL. Wrote the paper:
EM TL.
References
1. Ludwig J, Viggiano TR, McGill DB, Oh BJ (1980) Nonalcoholic steatohepatitis:
Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55:
434–438.
2. Haque M, Sanyal AJ (2002) The metabolic abnormalities associated with non-
alcoholic fatty liver disease. Best Pract Res Clin Gastroenterol 16: 709–731.
3. Day CP, James OF (1998) Steatohepatitis: a tale of two ‘‘hits’’? Gastroenterology
114: 842–845.
4. Larter CZ, Farrell GC (2006) Insulin resistance, adiponectin, cytokines in
NASH: Which is the best target to treat? J Hepatol 44: 253–261.
5. Hotamisligil GS (1999) The role of TNFalpha and TNF receptors in obesity and
insulin resistance. J Intern Med 245: 621–625.
6. Yin M, Wheeler MD, Kono H, Bradford BU, Gallucci RM, et al. (1999)
Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in
mice. Gastroenterology 117: 942–952.
7. Crespo J, Cayon A, Fernandez-Gil P, Hernandez-Guerra M, Mayorga M, et al.
(2001) Gene expression of tumor necrosis factor alpha and TNF-receptors, p55
and p75, in nonalcoholic steatohepatitis patients. Hepatology 34: 1158–1163.
8. Bahcecioglu IH, Yalniz M, Ataseven H, Ilhan N, Ozercan IH, et al. (2005)
Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with
nonalcoholic steatohepatitis. Hepatogastroenterology 52: 1549–53.
9. Memon RA, Grunfeld C, Feingold KR (2001) TNF-alpha is not the cause of
fatty liver disease in obese diabetic mice. Nat Med 7: 2–3.
1 0 .D e n gQ G ,S h eH ,C h e n gJ H ,F r e n c hS W ,K o o pD R ,e ta l .( 2 0 0 5 )
Steatohepatitis induced by intragastric overfeeding in mice. Hepatology 42:
905–914.
11. Feldstein AE, Werneburg NW, Canbay A, Guicciardi ME, Bronk SF, et al.
(2004) Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha
expression via a lysosomal pathway. Hepatology 40: 185–194.
12. Tomita K, Tamiya G, Ando S, Oshumi K, Chiyo T, et al. (2006) Tumour
necrosis factor alpha signalling through activation of Kupffer cells plays an
essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Gut 55:
415–424.
13. McCuskey RS, Ito Y, Robertson GR, McCuskey MK, Perry M, et al. (2004)
Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in
mice. Hepatology 40: 386–93.
14. Rinella ME, Green RM (2004) The methionine-choline deficient dietary model
of steatohepatitis does not exhibit insulin resistance. J Hepatol 40: 47–51.
15. Diehl AM (2005) Lessons from animal models of NASH. Hepatol Res 33:
138–144.
16. Yao ZM, Vance DE (1988) The active synthesis of phosphatidylcholine is
required for very low density lipoprotein secretion from rat hepatocytes. J Biol
Chem 263: 2998–3004.
17. Rinella ME, Elias MS, Smolak RR, Fu T, Borensztajn J, et al. (2008)
Mechanisms of steatohepatitis in mice fed a lipogenic methionine choline
deficient (MCD) diet. J Lipid Res 49: 1068–1076.
18. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, et al. (1994)
Impaired immune and acute-phase responses in interleukin-6-deficient mice.
Nature 368: 339–342.
19. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR
(1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the
histological lesions. Am J Gastroenterol 94: 2467–2474.
20. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, et al. (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver
disease. Hepatology 41: 1313–1321.
21. Bradford MM (1976) A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein-dye binding.
Anal Biochem 72: 248–254.
22. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation
and purification of total lipides from animal tissues. J Biol Chem 226: 497–509.
23. Ames BN (1966) Assay of inorganic phosphate, total phosphate and
phosphatases. Meth Enzymol 8: 115–118.
24. Bielawska A, Perry DK, Hannun YA (2001) Determination of ceramides and
diglycerides by the diglyceride kinase assay. Anal Biochem 298: 141–150.
25. George J, Pera N, Phung N, Leclercq I, Yun Hou J, et al. (2003) Lipid
peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of
chronic steatohepatitis. J Hepatol 39: 756–764.
26. Cuvillier O, Edsall L, Spiegel S (2000) Involvement of sphingosine in
mitochondria-dependent Fas-induced apoptosis of type II Jurkat T cells. J Biol
Chem 275: 15691–15700.
27. Natori S, Rust C, Stadheim LM, Srinivasan A, Burgart LJ, et al. (2001)
Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis.
J Hepatol 34: 248–253.
28. Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, et al. (2003)
Hepatocyte apoptosis and fas expression are prominent features of human
nonalcoholic steatohepatitis. Gastroenterology 125: 437–443.
29. Ribeiro PS, Cortez-Pinto H, Sola S, Castro RE, Ramalho RM, et al. (2004)
Hepatocyte apoptosis, expression of death receptors, and activation of NF-
kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients.
Am J Gastroenterol 99: 1708–1717.
30. Jin X, Zimmers TA, Perez EA, Pierce RH, Zhang Z, et al. (2006) Paradoxical
effects of short- and long-term interleukin-6 exposure on liver injury and repair.
Hepatology 43: 474–484.
31. Kirsch R, Clarkson V, Verdonk RC, Marais AD, Shepard EG, et al. (2006)
Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysac-
charide) and tumor necrosis factor alpha deficiency. J Gastroenterol Hepatol 21:
174–182.
32. Baumgardner JN, Shankar K, Hennings L, Badger TM, Ronis MJ (2007) A New
Model For Non-Alcoholic Steatohepatitis in the Rat Utilizing Total Enteral
Nutrition to Overfeed a High Polyunsaturated Fat Diet. Am J Physiol
Gastrointest Liver Physiol 294: G27–38.
IL-6 in MCD Diet-Induced NASH
PLoS ONE | www.plosone.org 9 November 2009 | Volume 4 | Issue 11 | e792933. Li Z, Agellon LB, Allen TM, Umeda M, Jewell L, et al. (2006) The ratio of
phosphatidylcholine to phosphatidylethanolamine influences membrane integ-
rity and steatohepatitis. Cell Metab 3: 321–331.
34. Puri P, Baillie RA, Wiest MM, Mirshahi F, Choudhury J, et al. (2007) A
lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 46: 1081–1090.
35. Holland WL, Brozinick JT, Wang LP, Hawkins ED, Sargent KM, et al. (2007)
Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and
obesity-induced insulin resistance. Cell Metab 5: 167–179.
36. Mari M, Fernandez-Checa JC (2007) Sphingolipid signalling and liver diseases.
Liver Int 27: 440–450.
37. Malagarie-Cazenave S, Andrieu-Abadie N, Se ´gui B, Gouaz V, Tardy C, et al.
(2002) Sphingolipid signalling: molecular basis and role in TNF–induced cell
death. Expert Rev Mol Med 2002. 1–15.
38. Malagarie-Cazenave S, Se ´gui B, Leveque S, Garcia V, Carpentier S, et al.
(2004) Role of FAN in tumor necrosis factor-alpha and lipopolysaccharide-
induced interleukin-6 secretion and lethality in D-galactosamine-sensitized mice.
J Biol Chem 279: 18648–18655.
39. Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, et al. (2000) CYP2E1
and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic
steatohepatitis. J Clin Invest 105: 1067–1075.
40. Dela Pena A, Leclercq I, Field J, George J, Jones B, et al. (2005) NF-kappaB
activation, rather than TNF, mediates hepatic inflammation in a murine dietary
model of steatohepatitis. Gastroenterology 129: 1663–1674.
41. Gyamfi MA, Damjanov I, French S, Wan YJ (2008) The pathogenesis of ethanol
versus methionine and choline deficient diet-induced liver injury. Biochem
Pharmacol 75: 981–995.
42. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, et al. (2002)
Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8: 75–79.
43. Senn JJ, Klover PJ, Nowak IA, Mooney RA (2002) Interleukin-6 induces cellular
insulin resistance in hepatocytes. Diabetes 51: 3391–3399.
44. Abiru S, Migita K, Maeda Y, Daikoku M, Ito M, et al. (2006) Serum cytokine
and soluble cytokine receptor levels in patients with non-alcoholic steatohepa-
titis. Liver Int 26: 39–45.
45. Haukeland JW, Damas JK, Konopski Z, Loberg EM, Haaland T, et al. (2006)
Systemic inflammation in nonalcoholic fatty liver disease is characterized by
elevated levels of CCL2. J Hepatol 44: 1167–1174.
46. Hill DB, Marsano L, Cohen D, Allen J, Shedlofsky S, et al. (1992) Increased
plasma interleukin-6 concentrations in alcoholic hepatitis. J Lab Clin Med 119:
547–552.
47. Pedersen BK, Fischer CP (2007) Physiological roles of muscle-derived
interleukin-6 in response to exercise. Curr Opin Clin Nutr Metab Care 10:
265–271.
48. Mooney RA (2007) Counterpoint: Interleukin-6 does not have a beneficial role
in insulin sensitivity and glucose homeostasis. J Appl Physiol 102: 816–818;
discussion 818-9.
49. Pedersen BK, Febbraio MA (2007) Point: Interleukin-6 does have a beneficial
role in insulin sensitivity and glucose homeostasis. J Appl Physiol 102: 814–816.
50. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, et al.
(1996) Liver failure and defective hepatocyte regeneration in interleukin-6-
deficient mice. Science 274: 1379–1383.
51. Deutschman CS, Cereda M, Ochroch EA, Raj NR (2006) Sepsis-induced
cholestasis, steatosis, hepatocellular injury, and impaired hepatocellular
regeneration are enhanced in interleukin-6 2/2 mice. Crit Care Med 34:
2613–2620.
52. Hong F, Radaeva S, Pan HN, Tian Z, Veech R, et al. (2004) Interleukin 6
alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty
liver disease. Hepatology 40: 933–941.
53. Hong F, Kim WH, Tian Z, Jaruga, Ishac E, et al. (2002) Elevated interleukin-6
during ethanol consumption acts as a potential endogenous protective cytokine
against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2
and Bcl-x(L) proteins. Oncogene 21: 32–43.
54. El-Assal O, Hong F, Kim WH, Radaeva S, Gao B (2004) IL-6-deficient mice are
susceptible to ethanol-induced hepatic steatosis: IL-6 protects against ethanol-
induced oxidative stress and mitochondrial permeability transition in the liver.
Cell Mol Immunol 1: 205–211.
55. McGettrick HM, Smith E, Filer A, Kissane S, Salmon M, et al. (2009)
Fibroblasts from different sites may promote or inhibit recruitment of flowing
lymphocytes by endothelial cells. Eur J Immunol 39: 113–125.
56. Kim JH, Bachmann RA, Chen J (2009) Interleukin-6 and insulin resistance.
Vitam Horm 80: 613–633.
57. Korn T, Betteli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 Cells. Annu
Rev Immunol 27: 485–517.
58. Scheller J, Rose-John S (2006) Interleukin-6 and its receptor: from bench to
bedside. Med Microbiol Immunol 195: 173–183.
59. Fernandez-Checa JC, Colell A, Mari M, Garcia-Ruiz C (2005) Ceramide, tumor
necrosis factor and alcohol-induced liver disease. Alcohol Clin Exp Res 29:
151S–157S.
60. Wieckowska A, Papouchado BG, Li Z, Lopez R, Zein NN, et al. (2008)
Increased hepatic and circulating interleukin-6 levels in human nonalcoholic
steatohepatitis. Am J Gastroenterol 103: 1372–1379.
IL-6 in MCD Diet-Induced NASH
PLoS ONE | www.plosone.org 10 November 2009 | Volume 4 | Issue 11 | e7929